Incremental diagnostic value and impact on patient management of somatostatin receptor scintigraphy with indium-111-pentetreotide in gastroenteropancreatic neuroendocrine tumors
Med Princ Pract. 2011;20(4):356-61.
Usmani S, Khan HA, Abdulla M, Ahmed N, abu Huda F, Marafi F, al Kandari F, al Mohannadi S, al Nafisi N.
Efficacia della scintigrafia con analogo della somatostatina (111-In-pentetreotide) in pazienti con tumori neuroendocrini gastro-entero-pancreatici.
111-In-pentetreotide/tumori neuroendocrini gastro-entero-pancreatici.
